Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Curr Protoc Mol Biol ; 119: 31.9.1-31.9.22, 2017 07 05.
Article in English | MEDLINE | ID: mdl-28678442

ABSTRACT

The ability to perform reverse genetics in the zebrafish model organism has been greatly advanced with the advent of the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated) system. The high level of efficiency in generating mutations when using the CRISPR/Cas9 system combined with the rapid generation time of the zebrafish model organism has made the possibility of performing F0 screens in this organism a reality. This unit describes a detailed protocol for performing an F0 screen using the CRISPR/Cas9 system in zebrafish starting with the design and production of custom CRISPR/Cas9 reagents for injection. Next, two approaches for determining the efficiency of mutation induction by the custom CRISPR/Cas9 reagents that are easily performed using standard molecular biology protocols are detailed. Finally, screening for F0 induced phenotypes using the zebrafish flh gene as an example is discussed. © 2017 by John Wiley & Sons, Inc.


Subject(s)
CRISPR-Cas Systems , Gene Editing/methods , Gene Knockout Techniques/methods , Genetic Testing/methods , Zebrafish/genetics , Animals
2.
PLoS One ; 11(4): e0153689, 2016.
Article in English | MEDLINE | ID: mdl-27081855

ABSTRACT

Mammalian microRNA expression is dysregulated in human cancer. However, the functional relevance of many microRNAs in the context of tumor biology remains unclear. Using CRISPR-Cas9 technology, we performed a global loss-of-function screen to simultaneously test the functions of individual microRNAs and protein-coding genes during the growth of a myeloid leukemia cell line. This approach identified evolutionarily conserved human microRNAs that suppress or promote cell growth, revealing that microRNAs are extensively integrated into the molecular networks that control tumor cell physiology. miR-155 was identified as a top microRNA candidate promoting cellular fitness, which we confirmed with two distinct miR-155-targeting CRISPR-Cas9 lentiviral constructs. Further, we performed anti-correlation functional profiling to predict relevant microRNA-tumor suppressor gene or microRNA-oncogene interactions in these cells. This analysis identified miR-150 targeting of p53, a connection that was experimentally validated. Taken together, our study describes a powerful genetic approach by which the function of individual microRNAs can be assessed on a global level, and its use will rapidly advance our understanding of how microRNAs contribute to human disease.


Subject(s)
CRISPR-Cas Systems , Genomics , Leukemia, Myeloid/pathology , MicroRNAs/genetics , Animals , Base Sequence , Cell Line, Tumor , Cell Proliferation/genetics , Conserved Sequence , Evolution, Molecular , Humans , Leukemia, Myeloid/genetics , Mice , Molecular Sequence Data , Tumor Suppressor Protein p53/genetics
3.
Proc Natl Acad Sci U S A ; 112(13): 4038-43, 2015 Mar 31.
Article in English | MEDLINE | ID: mdl-25775608

ABSTRACT

Conventional control strategies for mosquito-borne pathogens such as malaria and dengue are now being complemented by the development of transgenic mosquito strains reprogrammed to generate beneficial phenotypes such as conditional sterility or pathogen resistance. The widespread success of site-specific nucleases such as transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 in model organisms also suggests that reprogrammable gene drive systems based on these nucleases may be capable of spreading such beneficial phenotypes in wild mosquito populations. Using the mosquito Aedes aegypti, we determined that mutations in the FokI domain used in TALENs to generate obligate heterodimeric complexes substantially and significantly reduce gene editing rates. We found that CRISPR/Cas9-based editing in the mosquito Ae. aegypti is also highly variable, with the majority of guide RNAs unable to generate detectable editing. By first evaluating candidate guide RNAs using a transient embryo assay, we were able to rapidly identify highly effective guide RNAs; focusing germ line-based experiments only on this cohort resulted in consistently high editing rates of 24-90%. Microinjection of double-stranded RNAs targeting ku70 or lig4, both essential components of the end-joining response, increased recombination-based repair in early embryos as determined by plasmid-based reporters. RNAi-based suppression of Ku70 concurrent with embryonic microinjection of site-specific nucleases yielded consistent gene insertion frequencies of 2-3%, similar to traditional transposon- or ΦC31-based integration methods but without the requirement for an initial docking step. These studies should greatly accelerate investigations into mosquito biology, streamline development of transgenic strains for field releases, and simplify the evaluation of novel Cas9-based gene drive systems.


Subject(s)
Aedes/genetics , Clustered Regularly Interspaced Short Palindromic Repeats , DNA Repair , Gene Silencing , Mutagenesis, Insertional , Animals , Base Sequence , Dimerization , Exons , Genetic Vectors , Genome , Molecular Sequence Data , Mutation , Plasmids/metabolism , Polymerase Chain Reaction , RNA Editing , RNA, Double-Stranded/genetics , Recombination, Genetic , Temperature , Transgenes
4.
J Vis Exp ; (84): e51138, 2014 Feb 05.
Article in English | MEDLINE | ID: mdl-24561516

ABSTRACT

Zebrafish is a powerful vertebrate model system for studying development, modeling disease, and performing drug screening. Recently a variety of genetic tools have been introduced, including multiple strategies for inducing mutations and generating transgenic lines. However, large-scale screening is limited by traditional genotyping methods, which are time-consuming and labor-intensive. Here we describe a technique to analyze zebrafish genotypes by PCR combined with high-resolution melting analysis (HRMA). This approach is rapid, sensitive, and inexpensive, with lower risk of contamination artifacts. Genotyping by PCR with HRMA can be used for embryos or adult fish, including in high-throughput screening protocols.


Subject(s)
Genotyping Techniques/methods , Polymerase Chain Reaction/methods , Zebrafish/genetics , Animals , DNA/analysis , DNA/chemistry , DNA/genetics , Software
5.
G3 (Bethesda) ; 3(10): 1717-25, 2013 Oct 03.
Article in English | MEDLINE | ID: mdl-23979928

ABSTRACT

Zinc-finger nucleases have proven to be successful as reagents for targeted genome manipulation in Drosophila melanogaster and many other organisms. Their utility has been limited, however, by the significant failure rate of new designs, reflecting the complexity of DNA recognition by zinc fingers. Transcription activator-like effector (TALE) DNA-binding domains depend on a simple, one-module-to-one-base-pair recognition code, and they have been very productively incorporated into nucleases (TALENs) for genome engineering. In this report we describe the design of TALENs for a number of different genes in Drosophila, and we explore several parameters of TALEN design. The rate of success with TALENs was substantially greater than for zinc-finger nucleases , and the frequency of mutagenesis was comparable. Knockout mutations were isolated in several genes in which such alleles were not previously available. TALENs are an effective tool for targeted genome manipulation in Drosophila.


Subject(s)
Drosophila melanogaster/genetics , Endodeoxyribonucleases/genetics , Gene Targeting/methods , Animals , Endodeoxyribonucleases/chemistry , Endodeoxyribonucleases/metabolism , Zinc Fingers
6.
PLoS One ; 8(7): e69216, 2013.
Article in English | MEDLINE | ID: mdl-23874916

ABSTRACT

The Snail family of transcriptional regulators consists of three highly conserved members. These proteins regulate (repress) transcription via the recruitment of histone deacetylases to target gene promoters that possess the appropriate E-box binding sequences. Murine Snai1 is required for mouse development while Snai2 deficient animals survive with some anomalies. Less is known about the third member of the family, Snai3. To investigate the function of Snai3, we generated a conditional knockin mouse. Utilizing Cre-mediated deletion to facilitate the ablation of Snai3 in T cells or the entire animal, we found little to no effect of the loss of Snai3 in the entire animal or in T cell lineages. This finding provided the hypothesis that absence of Snai3 was mitigated, in part, by the presence of Snai2. To test this hypothesis we created Snai2/Snai3 double deficient mice. The developmental consequences of lacking both of these proteins was manifested in stunted growth, a paucity of offspring including a dramatic deficiency of female mice, and impaired immune cell development within the lymphoid lineages.


Subject(s)
Lymphocytes/cytology , Transcription Factors/deficiency , Animals , Female , Gene Expression Regulation, Developmental , Lymphocytes/metabolism , Male , Mice , Mice, Knockout , Snail Family Transcription Factors , Spleen/metabolism , Thymus Gland/metabolism , Transcription Factors/genetics
7.
PLoS One ; 8(5): e63074, 2013.
Article in English | MEDLINE | ID: mdl-23667577

ABSTRACT

MicroRNAs (miRNAs) have quickly emerged as important regulators of mammalian physiology owing to their precise control over the expression of critical protein coding genes. Despite significant progress in our understanding of how miRNAs function in mice, there remains a fundamental need to be able to target and edit miRNA genes in the human genome. Here, we report a novel approach to disrupting human miRNA genes ex vivo using engineered TAL-effector (TALE) proteins to function as nucleases (TALENs) that specifically target and disrupt human miRNA genes. We demonstrate that functional TALEN pairs can be designed to enable disruption of miRNA seed regions, or removal of entire hairpin sequences, and use this approach to successfully target several physiologically relevant human miRNAs including miR-155*, miR-155, miR-146a and miR-125b. This technology will allow for a substantially improved capacity to study the regulation and function of miRNAs in human cells, and could be developed into a strategic means by which miRNAs can be targeted therapeutically during human disease.


Subject(s)
Endonucleases/metabolism , Genetic Engineering , MicroRNAs/genetics , Alleles , Animals , Base Sequence , Genetic Loci/genetics , Genome, Human/genetics , HEK293 Cells , Humans , Mice , Molecular Sequence Data , Mutation Rate , Nucleic Acid Conformation , Sequence Deletion/genetics , Transfection
8.
Genes Cells ; 18(6): 450-8, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23573916

ABSTRACT

The heteroduplex mobility assay (HMA) is widely used to characterize strain variants of human viruses. To determine whether it can detect small sequence differences in homologous templates, we constructed a series of deletion constructs (1-10 bp deletions) in the multiple cloning site (MCS) of pBluescript II. After PCR amplification of the MCS using a mixture of wild-type and one of the deletion constructs, the resulting PCR amplicons were electrophoresed using 15% polyacrylamide gels. Two types of heteroduplexes exhibited retarded electrophoretic migration compared with individual homoduplexes. Therefore, we applied this HMA to detect transcription activator-like effector nucleases (TALEN)-induced insertion and/or deletion (indel) mutations at an endogenous locus. We found that TALEN in vivo activity was easily estimated by the degree of multiple HMA profiles derived from TALEN-injected F0 embryos. Furthermore, TALEN-injected F0 founder fish produced several unique HMA profiles in F1 embryos. Sequence analysis confirmed that the different HMA profiles contained distinct indel mutations. Thus, HMA is a rapid and sensitive analytical method for the detection of the TALEN-mediated genome modifications.


Subject(s)
Deoxyribonucleases/metabolism , Genome/genetics , Heteroduplex Analysis , Zebrafish/genetics , Animals , INDEL Mutation/genetics
9.
PLoS Genet ; 8(8): e1002861, 2012.
Article in English | MEDLINE | ID: mdl-22916025

ABSTRACT

The zebrafish is a powerful experimental system for uncovering gene function in vertebrate organisms. Nevertheless, studies in the zebrafish have been limited by the approaches available for eliminating gene function. Here we present simple and efficient methods for inducing, detecting, and recovering mutations at virtually any locus in the zebrafish. Briefly, double-strand DNA breaks are induced at a locus of interest by synthetic nucleases, called TALENs. Subsequent host repair of the DNA lesions leads to the generation of insertion and deletion mutations at the targeted locus. To detect the induced DNA sequence alterations at targeted loci, genomes are examined using High Resolution Melt Analysis, an efficient and sensitive method for detecting the presence of newly arising sequence polymorphisms. As the DNA binding specificity of a TALEN is determined by a custom designed array of DNA recognition modules, each of which interacts with a single target nucleotide, TALENs with very high target sequence specificities can be easily generated. Using freely accessible reagents and Web-based software, and a very simple cloning strategy, a TALEN that uniquely recognizes a specific pre-determined locus in the zebrafish genome can be generated within days. Here we develop and test the activity of four TALENs directed at different target genes. Using the experimental approach described here, every embryo injected with RNA encoding a TALEN will acquire targeted mutations. Multiple independently arising mutations are produced in each growing embryo, and up to 50% of the host genomes may acquire a targeted mutation. Upon reaching adulthood, approximately 90% of these animals transmit targeted mutations to their progeny. Results presented here indicate the TALENs are highly sequence-specific and produce minimal off-target effects. In all, it takes about two weeks to create a target-specific TALEN and generate growing embryos that harbor an array of germ line mutations at a pre-specified locus.


Subject(s)
Endonucleases/genetics , Gene Targeting/methods , Mutagenesis, Site-Directed/methods , Software , Zebrafish/genetics , Animals , Base Sequence , Binding Sites , Cloning, Molecular , DNA Breaks, Double-Stranded , Embryo, Nonmammalian , Endonucleases/biosynthesis , Genetic Loci , Germ-Line Mutation , Microinjections , Molecular Sequence Data , Nucleic Acid Denaturation , Polymorphism, Genetic , Protein Binding , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Zebrafish/embryology
10.
Eur J Immunol ; 42(4): 1038-43, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22531927

ABSTRACT

The altered expression of transcription factors in hematopoietic stem cells and their subsequent lineages can alter the development of lymphoid and myeloid lineages. The role of the transcriptional repressor Snai3 protein in the derivation of cells of the hemato-poietic system was investigated. Snai3 is expressed in terminal T-cell and myeloid lineages, therefore, we chose to determine if expressing Snai3 in the early stages of hematopoietic development would influence cell-lineage determination. Expression of Snai3 by retroviral transduction of hematopoietic stem cells using bone marrow chimera studies demonstrated a block in lymphoid-cell development and enhanced expansion of myeloid-lineage cells. Analysis of Snai3-expressing hematopoietic precursor cells showed normal numbers of immature cells, but a block in the development of cells committed to lymphoid lineages. These data indicate that the overexpression of Snai3 does alter bone marrow cell development and that the identification of genes whose expression is altered by the presence of Snai3 would aid in our understanding of these developmental pathways.


Subject(s)
Gene Expression Regulation/immunology , Lymphocytes/immunology , Myeloid Cells/immunology , Repressor Proteins/immunology , Transcription Factors/immunology , Animals , Bone Marrow Cells/immunology , Bone Marrow Cells/metabolism , Cell Differentiation/physiology , Gene Expression Regulation/genetics , Lymphocytes/metabolism , Mice , Mice, Transgenic , Myeloid Cells/metabolism , Repressor Proteins/biosynthesis , Repressor Proteins/genetics , Snail Family Transcription Factors , Transcription Factors/biosynthesis , Transcription Factors/genetics , Transduction, Genetic
11.
J Leukoc Biol ; 80(2): 383-98, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16735694

ABSTRACT

The mouse Pactolus and CD18 genes are highly conserved paralogues. The expression patterns of these genes are diverse in that most cells of hematopoietic lineage express CD18, but Pactolus is only expressed by maturing neutrophils. The minimal promoters of these two genes are homologous, including the conservation of two tandem PU.1-binding sites upstream of the transcriptional start site. To define the means by which these two structurally similar but functionally distinct promoters operate, a series of reporter assays, electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation analyses, were performed. Transfection of Pactolus constructs into mouse macrophages, which do not express Pactolus, defined a negative control element within the first 100 base pairs. The presence of this negative regulatory site, distinct from the PU.1-binding site, was confirmed by EMSA oligonucleotide competition and gene reporter assays of Pactolus/CD18 chimeric constructs. Although PU.1 binding can be detected on Pactolus and CD18 minimal promoter segments with EMSA, only the CD18 promoter shows PU.1 binding in vivo, suggesting that the negative regulatory protein may block PU.1 from binding to the Pactolus promoter, thus inhibiting transcription of the gene. Sequence analysis of the negative control region in the Pactolus promoter suggested potential control by Snail and/or Smad families of transcription regulators. EMSA supershift analysis with antibodies against these proteins, using extracts from macrophages and mucosal mast cells, identified specific binding of Smuc to the promoter element, including a Smuc/PU.1/DNA trimeric complex. These data implicate Smuc as blocking Pactolus transcription in cells expressing PU.1 (and CD18) but not Pactolus.


Subject(s)
CD18 Antigens/genetics , Gene Expression Regulation , Integrin beta1/genetics , Transcription, Genetic , Animals , Base Sequence , Binding Sites , Cell Line , Down-Regulation , Evolution, Molecular , Mice , Molecular Sequence Data , Promoter Regions, Genetic , Proto-Oncogene Proteins/genetics , Snail Family Transcription Factors , Trans-Activators/genetics , Transcription Factors/metabolism , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...